Parkinson's Disease Dementia

11 clinical trials · Condition

Record	Firm	Date
To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia (NCT03413384)	BrainX Corporation	2019-02-15
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder (NCT02871427)	Axovant Sciences Ltd.	2016-10-20
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia (NCT02910102)	Axovant Sciences Ltd.	2016-10-01
Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) (NCT02708186)	Axovant Sciences Ltd.	2016-03-01
Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies (NCT02702102)	Columbia University	2015-12-01
Ambroxol as a Treatment for Parkinson's Disease Dementia (NCT02914366)	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	2015-11-01
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001 (NCT02281474)	Georgetown University	2014-11-01
An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia (NCT01102582)	The Catholic University of Korea	2010-04-01
Cerebro Spinal Fluid Collection (CSF) (NCT04844060)	University Hospital, Strasbourg, France	2010-02-01
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) (NCT00623103)	Novartis	2008-01-01
Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies (NCT00855686)	H. Lundbeck A/S	2007-01-01

Track Parkinson's Disease Dementia automatically

Every clearance here is in the API, with alerts when new ones post.